| 1 |
Fass R, Boeckxstaens GE, El-Serag H, et al. Gastro-oesophageal reflux disease[J]. Nat Rev Dis Primers, 2021,7(1):55.
|
| 2 |
Zheng Z, Shang Y, Wang N, et al. Current advancement on the dynamic mechanism of gastroesophageal reflux disease[J]. Int J Biol Sci, 2021,17(15):4154-4164.
|
| 3 |
Ustaoglu A, Nguyen A, Spechler S, et al. Mucosal pathogenesis in gastro- esophageal reflux disease[J]. Neurogastroenterol Motil, 2020, 32(12):e14022.
|
| 4 |
Morozov S, Sentsova T. Local inflammatory response to gastroesophageal reflux: association of gene expression of inflammatory cytokines with esophageal multichannel intraluminal impedance-pH data[J]. World J Clin Cases, 2022, 10(26):9254-9263.
|
| 5 |
Kerber EL, Padberg C, Koll N, et al. The importance of hypoxia-inducible factors (HIF-1 and HIF-2) for the pathophysiology of inflammatory bowel disease[J]. Int J Mol Sci, 2020, 21(22):8551.
|
| 6 |
Singhal R, Shah YM. Oxygen battle in the gut: hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine[J]. J Biol Chem, 2020, 295(30):10493-10505.
|
| 7 |
Huo X, Agoston AT, Dunbar KB, et al. Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GERD[J]. Gut, 2017, 66(9):1542-1554.
|
| 8 |
Brown E, Rowan C, Strowitzki MJ, et al. Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patients[J]. FASEB J, 2020, 34(3):3732-3742.
|
| 9 |
Souza RF, Bayeh L, Spechler SJ, et al. A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: a potential role for targeting HIF-2α to prevent and treat reflux esophagitis[J]. Curr Opin Pharmacol, 2017, 37:93-99.
|
| 10 |
Ji Z, Bao S, Li L, et al. Hypoxia-inducible factor-2α promotes EMT in esophageal squamous cell carcinoma through the Notch pathway[J]. Adv Clin Exp Med, 2022, 31(7):795-805.
|
| 11 |
Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription factors--similar but not identical[J]. Mol Cells, 2010, 29(5):435-442.
|
| 12 |
Shah YM, Ito S, Morimura K, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade[J]. Gastroenterology, 2008, 134(7):2036-2048, 2048.e1-3.
|
| 13 |
Souza RF. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia[J]. J Gastroenterol, 2017, 52(7):767-776.
|
| 14 |
Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation[J]. J Physiol, 2008, 586(17):4055-4059.
|
| 15 |
崔亚,邓海鹏,焦黛妍. 六君子汤合旋覆代赭汤治疗反流性食管炎临床疗效及对HIF-2α/NF-κB信号通路的影响[J]. 辽宁中医杂志,2023,50(1):58-62.
|
| 16 |
Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes[J]. JAMA, 2016, 315(19):2104-2012.
|
| 17 |
Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study[J]. Aliment Pharmacol Ther, 2012, 35(1):154-164.
|
| 18 |
Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis[J]. Am J Gastroenterol, 2003, 98(3):551-6. DOI: 10.1111/j.1572-0241.2003.07303.x.
|
| 19 |
Guarino MP, Cheng L, Ma J,et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease[J]. Neurogastroenterol Motil, 2010, 22(7):746-751, e219.DOI: 10.1111/j.1365-2982.2 010.01514.x.
|
| 20 |
|
| 21 |
Peles S, Medda BK, Zhang Z,et al. Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats[J]. Neuroscience, 2009, 161(2):515-25.DOI: 10.1016 /j.neuroscience.2009.03.040.
|
| 22 |
Cheng L, de la Monte S, Ma J, et al. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa[J]. Am J Physiol Gastrointest Liver Physiol. 2009, 297(1):G135-43. DOI: 10.1152/ajpgi.90386.2008.
|
| 23 |
Ma J, Altomare A, Guarino M,et al. HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303(5):G635-G645. DOI: 10.1152/ajpgi.00097.2012.
|
| 24 |
Silva RO, Bingana RD, Sales TMAL,et al.Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease[J]. Neurogastroenterol Motil, 2018, 23:e13340. DOI: 10.1111/nmo.13340.
|
| 25 |
|
| 26 |
Fujino K, de la Fuente SG, Takami Y, et al. Attenuation of acid induced oesophagitis in VR-1 deficient mice[J]. Gut, 2006, 55(1):34-40.DOI: 10.1136/ gut.2005.066795. Epub 2005 Aug 9.
|
| 27 |
Wang Y, Cui L, Xu H, et al. TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway[J]. Atherosclerosis, 2017, 260:13-19. DOI: 10.1016/j.atherosclerosis.2017.03.016.
|
| 28 |
Woodland P, Shen Ooi JL, Grassi F, et al. Superficial esophageal mucosal afferent nerves may contribute to reflux hypersensitivity in nonerosive reflux disease[J]. Gastroenterology, 2017, 153(5):1230-1239. DOI: 10.1053/j.gastro. 2017.07.017.
|
| 29 |
Xu X, Li Z, Zou D, et al. High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease[J]. Dig Dis Sci, 2013, 58(1):53-60. DOI: 10.1007/s10620-012-2308-z.
|
| 30 |
Harnett KM, Rieder F, Behar J, Biancani P. Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa[J]. J Neurogastroenterol Motil, 2010, 16(4):374-88.
|
| 31 |
Hong SJ, Park SH, Moon JS, et al. The benefits of combination therapy with esomeprazole and rebamipide in symptom improvement in reflux esophagitis: an international multicenter study[J]. Gut Liver, 2016, 10(6):910-916. DOI: 10.5009/gnl15537.
|
| 32 |
|
| 33 |
Lee JA, Shin MR, Kim MJ, et al. Protective Effects of Inflammation of Curcumae Longae Rhizoma 30% EtOH Extract on Acute Reflux Esophagitis Rats[J]. Biomed Res Int, 2021, 2021:8854945. DOI: 10.1155/2021/8854945.
|
| 34 |
Yoo SK, Starnes TW, Deng Q, et al. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo[J]. Nature, 2011, 480(7375):109-12. DOI: 10.1038/ nature10632.
|
| 35 |
Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence[J]. Exp Biol Med (Maywood), 2012, 237(5):474-80. DOI: 10.1258/ebm.2011.011358.
|
| 36 |
Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species[J]. Nat Rev Immunol, 2013, 13(5):349-61. DOI: 10.1038/nri3423.
|
| 37 |
Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury[J]. Gastroenterology, 2009, 137(5):1776-84.DOI: 10.1053/j.gastro.2009.
|
| 38 |
Altomare A, Guarino MP, Cocca S, et al. Gastroesophageal reflux disease: Update on inflammation and symptom perception[J]. World J Gastroenterol, 2013, 19(39):6523-8. DOI: 10.3748/wjg.v19.i39.6523.
|
| 39 |
Zavala-Solares MR, Fonseca-Camarillo G, Valdovinos M, et al. Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study[J]. BMC Gastroenterol, 2021, 21(1):201. DOI: 10.1186/s12876-021-01707-7.
|